REG - Goldman Sachs & Co. Avadel Pharma plc - Form 38.5b - AVADEL PHARMACEUTICALS PLC)
Goldman Sachs & Co. LLC disclosed dealings in Avadel Pharmaceuticals plc under the Irish Takeover Panel rules. As of December 24, 2025, Goldman Sachs holds 720,066 long positions and 486,150 short positions in Avadel's USD 0.01 ordinary shares. The report includes details of various transactions, including sales and purchases of shares, and indicates that Goldman Sachs is an advisor to the offeree, Avadel Pharmaceuticals. The disclosure was made on December 25, 2025, with a supplemental form attached.
London Stock Exchange·